Literature DB >> 11096734

Diabetic Neuropathies.

.   

Abstract

There are currently no treatments available (beyond optimal control of hyperglycemia) that arrest or reverse progressive diabetic polyneuropathy. Consultation with a diabetologist is indicated for patients with poorly controlled disease and polyneuropathy. Immunotherapy for diabetic lumbosacral plexopathy has been advocated but is not supported to date by class 1 clinical trial evidence. Pharmacologic treatment for painful neuropathy may include topical anesthetics, capsaicin cream, anticonvulsants, tricyclic antidepressants, mexiletine, and opioids. Gabapentin, a newer anticonvulsant, has an attractive side-effect profile (a consideration in older patients) and has fewer interactions with other drugs. Amitriptyline may cause excessive sedation, postural hypotension, constipation, and urinary retention, but low evening doses (10 to 25 mg), slowly titrated upward, may offer relief from nocturnal pain. Opioids should not be withheld from patients with severe pain or with intolerance of or contraindications to other agents. A single physician should supervise their use.

Entities:  

Year:  2000        PMID: 11096734     DOI: 10.1007/s11940-000-0021-2

Source DB:  PubMed          Journal:  Curr Treat Options Neurol        ISSN: 1092-8480            Impact factor:   3.598


  47 in total

1.  Sural nerve oxygen tension in diabetes.

Authors:  P G Newrick; A J Wilson; J Jakubowski; A J Boulton; J D Ward
Journal:  Br Med J (Clin Res Ed)       Date:  1986-10-25

Review 2.  Diabetic neuropathies.

Authors:  A A Sima; P K Thomas; D Ishii; A Vinik
Journal:  Diabetologia       Date:  1997-10       Impact factor: 10.122

3.  Diabetes increases sciatic nerve susceptibility to endothelin-induced ischemia.

Authors:  D W Zochodne; C Cheng; H Sun
Journal:  Diabetes       Date:  1996-05       Impact factor: 9.461

4.  Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy.

Authors:  M B Max; S A Lynch; J Muir; S E Shoaf; B Smoller; R Dubner
Journal:  N Engl J Med       Date:  1992-05-07       Impact factor: 91.245

5.  Effects of very mild versus overt diabetes on vascular haemodynamics and barrier function in rats.

Authors:  G Pugliese; R G Tilton; A Speedy; K Chang; E Santarelli; M A Province; D Eades; W R Sherman; J R Williamson
Journal:  Diabetologia       Date:  1989-12       Impact factor: 10.122

6.  Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial.

Authors:  M Backonja; A Beydoun; K R Edwards; S L Schwartz; V Fonseca; M Hes; L LaMoreaux; E Garofalo
Journal:  JAMA       Date:  1998-12-02       Impact factor: 56.272

7.  Nodal Na(+)-channel displacement is associated with nerve-conduction slowing in the chronically diabetic BB/W rat: prevention by aldose reductase inhibition.

Authors:  P V Cherian; M Kamijo; K J Angelides; A A Sima
Journal:  J Diabetes Complications       Date:  1996 Jul-Aug       Impact factor: 2.852

8.  Double-blind, placebo-controlled study of the application of capsaicin cream in chronic distal painful polyneuropathy.

Authors:  Phillip A Low; Tonette L Opfer-Gehrking; Peter J Dyck; William J Litchy; Peter C O'Brien
Journal:  Pain       Date:  1995-08       Impact factor: 6.961

Review 9.  Management of idiopathic, diabetic and miscellaneous gastroparesis with cisapride.

Authors:  M C Champion
Journal:  Scand J Gastroenterol Suppl       Date:  1989

10.  The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus.

Authors:  P Reichard; B Y Nilsson; U Rosenqvist
Journal:  N Engl J Med       Date:  1993-07-29       Impact factor: 91.245

View more
  1 in total

1.  Evaluation of the efficacy of pulsed electromagnetic field in the management of patients with diabetic polyneuropathy.

Authors:  Vinay Graak; Sarika Chaudhary; B S Bal; J S Sandhu
Journal:  Int J Diabetes Dev Ctries       Date:  2009-04
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.